GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (NAS:MMSI) » Definitions » Gross Profit

MMSI (Merit Medical Systems) Gross Profit : $643 Mil (TTM As of Dec. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Merit Medical Systems Gross Profit?

Merit Medical Systems's gross profit for the three months ended in Dec. 2024 was $173 Mil. Merit Medical Systems's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $643 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Merit Medical Systems's gross profit for the three months ended in Dec. 2024 was $173 Mil. Merit Medical Systems's Revenue for the three months ended in Dec. 2024 was $355 Mil. Therefore, Merit Medical Systems's Gross Margin % for the quarter that ended in Dec. 2024 was 48.71%.

Merit Medical Systems had a gross margin of 48.71% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Merit Medical Systems was 47.43%. The lowest was 41.62%. And the median was 44.77%.


Merit Medical Systems Gross Profit Historical Data

The historical data trend for Merit Medical Systems's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems Gross Profit Chart

Merit Medical Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 401.18 485.33 519.10 583.87 643.33

Merit Medical Systems Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.53 151.72 161.10 157.54 172.98

Competitive Comparison of Merit Medical Systems's Gross Profit

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Gross Profit distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's Gross Profit falls into.


;
;

Merit Medical Systems Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Merit Medical Systems's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=1356.514 - 713.181
=643

Merit Medical Systems's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=355.158 - 182.175
=173

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $643 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Merit Medical Systems's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=173 / 355.158
=48.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Merit Medical Systems  (NAS:MMSI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Merit Medical Systems had a gross margin of 48.71% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Merit Medical Systems Gross Profit Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Merit Medical Systems Business Description

Traded in Other Exchanges
Address
1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Executives
Fred P Lampropoulos director, officer: President & CEO
Brian G. Lloyd officer: Chief Legal Officer, Secretary 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Raul Jr. Parra officer: Interim CFO 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen C. Evans director C/O ALARM.COM HOLDINGS, INC., 8281 GREENSBORO DRIVE, SUITE 100, TYSONS VA 22102
Neil Peterson officer: Chief Operating Officer 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Michel James Voigt officer: Chief Human Resources Officer 1600 W MERIT PARKWAY, SOUTH JORDAN UT 84095
F. Ann Millner director 4275 SPRING ROAD, OGDEN UT 84403
Joseph Wright officer: President, International 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Thomas James Gunderson director 5905 LONG BRAKE TRAIL, EDINA MN 55439
A Scott Anderson director ONE SOUTH MAIN, SUITE 1134, SALT LAKE CITY UT 84111
Lynne Ward director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Ronald Frost officer: Chief Operating Officer 1600 WEST MERIT PARKWAY, SOUTH JORDAN X1 84095
Robert Fredericks officer: Chief Strategy & Innovation O. 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Michael R Mcdonnell director C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Laura S. Kaiser director 10101 WOODFIELD LANE, ST. LOUIS MO 63132